All papers - OPEN Foundation

Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD use

Luethi, D., Hoener, M. C., Krähenbühl, S., Liechti, M. E., & Duthaler, U. | Biochemical pharmacology | 11 April 2019

Brown, T. K., Noller, G. E., & Denenberg, J. O. | Journal of psychoactive drugs | 9 April 2019

Effects of the Psychedelic Amphetamine MDA (3,4-Methylenedioxyamphetamine) in Healthy Volunteers.

Baggott, M. J., Garrison, K. J., Coyle, J. R., Galloway, G. P., Barnes, A. J., Huestis, M. A., & Mendelson, J. E. | Journal of psychoactive drugs | 9 April 2019

Psychedelic-Assisted Group Therapy: A Systematic Review.

Trope, A., Anderson, B. T., Hooker, A. R., Glick, G., Stauffer, C., & Woolley, J. D. | Journal of Psychoactive Drugs | 5 April 2019

Receptor-Enriched Analysis of functional connectivity by targets (REACT): A novel, multimodal analytical approach informed by PET to study the pharmacodynamic response of the brain under MDMA

Dipasquale, O., Selvaggi, P., Veronese, M., Gabay, A. S., Turkheimer, F., Mehta, M. A. | NeuroImage | 4 April 2019

Oxytocin-dependent reopening of a social reward learning critical period with MDMA

Nardou, R., Lewis, E. M., Rothhaas, R., Xu, R., Yang, A., Boyden, E., & Dölen, G. | Nature | 3 April 2019

Classic psychedelics: the special role of the visual system

Császár-Nagy, N., Kapócs, G., & Bókkon, I. | Reviews in the neurosciences | 2 April 2019

Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration.

Fadiman, J., & Korb, S. | Journal of psychoactive drugs | 29 March 2019

Sensitization to the prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA).

Curry, D. W., Berro, L. F., Belkoff, A. R., Sulima, A., Rice, K. C., & Howell, L. L. | Neuropharmacology | 25 March 2019

Embracing Neurodiversity in Psychedelic Science: A Mixed-Methods Inquiry into the MDMA Experiences of Autistic Adults

Danforth, A. L. | Journal of psychoactive drugs | 25 Mar 2019

Salvia divinorum: from recreational hallucinogenic use to analgesic and anti-inflammatory action

Coffeen, U., & Pellicer, F. | Journal of pain research | 22 March 2019

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy.

Sessa, B., Higbed, L., & Nutt, D. | Frontiers in Psychiatry | 20 March 2019

Combining Cognitive-Behavioral Conjoint Therapy for PTSD with 3,4-Methylenedioxymethamphetamine (MDMA): A Case Example.

Wagner, A. C., Mithoefer, M. C., Mithoefer, A. T., & Monson, C. M. | Journal of psychoactive drugs | 19 March 2019

Ketamine: A Paradigm Shift for Depression Research and Treatment

Krystal, J. H., Abdallah, C. G., Sanacora, G., Charney, D. S., & Duman, R. S. | Neuron | 6 March 2019

Beyond LSD: A Broader Psychedelic Zeitgeist during the Early to Mid-20th Century.

Aday, J. S., Bloesch, E. K., & Davoli, C. C. | Journal of psychoactive drugs | 6 March 2019

Ibogaine Administration Modifies GDNF and BDNF Expression in Brain Regions Involved in Mesocorticolimbic and Nigral Dopaminergic Circuits.

Marton, S., González, B., Rodríguez, S., Miquel, E., Martínez-Palma, L., Pazos, M., ... & Scorza, C. | Frontiers in pharmacology | 5 March 2019

Chronic, Intermittent Microdoses of the Psychedelic N, N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents.

Cameron, L. P., Benson, C. J., DeFelice, B. C., Fiehn, O., & Olson, D. E. | ACS chemical neuroscience | 4 March 2019

Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents

Cameron, L. P., Benson, C. J., DeFelice, B. C., Fiehn, O., & Olson, D. E. | ACS chemical neuroscience | 4 March 2019

5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety

Davis, A. K., So, S., Lancelotta, R., Barsuglia, J. P., & Griffiths, R. R.| The American journal of drug and alcohol abuse | 1 March 2019

Psychedelics and Dying Care: A Historical Look at the Relationship between Psychedelics and Palliative Care.

Dyck, E. | Journal of psychoactive drugs | 1 March 2019

Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers

Erritzoe, D., Smith, J., Fisher, P. M., Carhart-Harris, R., Frokjaer, V. G., & Knudsen, G. M.| Journal of Psychopharmacology | 28 February 2019